DIA421.92-0.55 -0.13%
SPX5,888.78-23.39 -0.40%
IXIC19,055.87-120.01 -0.63%

12 Health Care Stocks Moving In Tuesday's After-Market Session

Benzinga·05/27/2025 21:06:12
Listen to the news

Gainers

  • AEON Biopharma (AMEX:AEON) stock moved upwards by 10.9% to $0.67 during Tuesday's after-market session. The company's market cap stands at $7.6 million.
  • Innovative Eyewear (NASDAQ:LUCY) shares increased by 7.01% to $3.05. The company's market cap stands at $9.4 million.
  • Universe Pharmaceuticals (NASDAQ:UPC) shares moved upwards by 5.62% to $4.88. The market value of their outstanding shares is at $74.2 million.
  • Korro Bio (NASDAQ:KRRO) shares rose 5.56% to $13.46. The company's market cap stands at $126.3 million.
  • CARISMA Therapeutics (NASDAQ:CARM) shares increased by 5.0% to $0.2. The company's market cap stands at $8.3 million.
  • Prelude Therapeutics (NASDAQ:PRLD) stock moved upwards by 5.0% to $0.84. The company's market cap stands at $47.4 million.

Losers

  • Imunon (NASDAQ:IMNN) stock declined by 17.2% to $1.88 during Tuesday's after-market session. The market value of their outstanding shares is at $32.9 million.
  • PharmaCyte Biotech (NASDAQ:PMCB) shares declined by 12.85% to $0.95. The market value of their outstanding shares is at $6.5 million.
  • SCWorx (NASDAQ:WORX) shares fell 8.68% to $0.62. The market value of their outstanding shares is at $2.2 million.
  • Wellgistics Health (NASDAQ:WGRX) shares declined by 7.21% to $2.32. The company's market cap stands at $166.7 million.
  • Biote (NASDAQ:BTMD) stock fell 7.11% to $3.79. The market value of their outstanding shares is at $119.3 million.
  • Senti Biosciences (NASDAQ:SNTI) shares declined by 6.79% to $3.05. The company's market cap stands at $79.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.